x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Proactive - Interviews for investors

Welcome to the Proactive podcast channel – the destination for breaking news on growth companies and up to the minute market coverage. Here we plug you into what’s new and exciting in the world of business.

business investing

All Episodes

00:02:45

EnWave expands partnership with Procescir, enabling...

Proactive - Interviews for investors ·

2025/06/12

EnWave Corporation CEO Brent Charleton joined Steve Darling from Proactive to announce a significant expansion of the company’s partnership with Procescir S.A. de C.V., a food manufacturer based in Mexico. The companies have signed an amendment to their royalty-bearing license agreement, marking a pivotal step in EnWave’s strategy to grow its international footprint in the natural snack sector. The newly signed amendment expands the scope of the license to include a wider range of fruit and

en

00:03:42

Aftermath Silver reports final Phase 2 assays,...

Proactive - Interviews for investors ·

2025/06/11

Aftermath Silver CEO Ralph Rushton joined Steve Darling from Proactive to discuss the final assay results from the company’s Phase 2 diamond drill program at the Berenguela silver-copper-manganese deposit in southern Peru. The results include 12 additional drill holes from the broader 82-hole program and confirm the mineral resource remains open to the east.Rushton highlighted that Hole AFD139, located on the most easterly section of the drill program, returned a notable intercept of 68.9 metres

en

00:05:29

NATO spending surge: European defense stocks and...

Proactive - Interviews for investors ·

2025/06/11

Jane Edmondson VettaFi Head of Index Product Strategy at TMXVettaFi joined Steve Darling from Proactive to introduce the firm's latest innovation in thematic investing: the Army Future of Defense ETF. The new fund follows on the heels of VettaFi’s highly successful NATO Future Defense UCITS ETF, which recently surpassed $2.5 billion in assets under management, reflecting intense investor demand for defense-sector exposure. Edmondson explained that while the NATO ETF focuses broadly on global

en

00:05:22

Lahontan Gold expands Santa Fe Mine drilling program...

Proactive - Interviews for investors ·

2025/06/11

Lahontan Gold Corp CEO Kimberly Ann joined Steve Darling from Proactive to announce a significant milestone in the advancement of the company’s flagship Santa Fe Mine project in Nevada. The company has received formal approval from the United States Bureau of Land Management (BLM) for an amendment allowing additional drill sites on unpatented lode mining claims situated on BLM-administered federal lands. This regulatory green light marks a pivotal step forward for Lahontan, enabling the initiation

en

00:04:52

Bango reports strong FY2024 results, highlights...

Proactive - Interviews for investors ·

2025/06/11

Bango CFO Matt Wilson joined Steve Darling from Proactive to discuss the company’s full-year results for the 12 months ending December 31, 2024, along with its outlook for 2025. The company reported a pivotal year marked by robust revenue growth, rising profitability, and continued momentum across its Digital Vending Machine® (DVM) and Payments segments. For FY2024, Bango posted a 16% increase in total revenue and more than doubled its Adjusted EBITDA to $15.3 million. This reflects both the

en

00:04:24

Harfang Exploration plans summer 2025 program to...

Proactive - Interviews for investors ·

2025/06/11

Harfang Exploration CEO Rick Breger joined Steve Daring from Proactive to unveil plans for the company’s upcoming 2025 summer exploration program at the Sky Lake Gold Project in northwestern Ontario. This initiative is set to build on the momentum of the company’s successful winter diamond drilling campaign and aims to expand geological understanding across the broader land package. The summer fieldwork will include a combination of prospecting, detailed geological mapping, and channel sampling

en

00:06:41

Sprott CEO: U.S. nuclear policy shift and AI energy...

Proactive - Interviews for investors ·

2025/06/11

Sprott Asset Management CEO John Ciampaglia spoke with Steve Darling from Proactive to discuss the transformative changes underway in the uranium market and the pivotal role of the Sprott Physical Uranium ETC, developed in partnership with HANetf. Ciampaglia described the current market landscape as "unprecedented," driven by sweeping shifts in U.S. nuclear energy policy and intensifying energy demands from emerging technologies. A key focus of the discussion was the dramatic policy push from the

en

00:05:57

Medicus Pharma submits development plan for novel...

Proactive - Interviews for investors ·

2025/06/10

Medicus Pharma CEO Dr Raza Bokhari joined Steve Darling from Proactive to announce the submission of a comprehensive product development plan to the U.S. FDA for the treatment of external squamous cell carcinoma (SCC) in horses. The submission was made under the Investigational New Animal Drug (INAD) program and seeks concurrence under the Minor Use in Major Species (MUMS) designation. The FDA recently granted MUMS designation to Medicus Pharma’s dissolvable Doxorubicin-containing microneedle

en

00:03:17

First Phosphate earns U.S. DoD eligibility rating for...

Proactive - Interviews for investors ·

2025/06/10

First Phosphate Corp. CEO John Passalacqua joined Steve Darling from Proactive to announce a strategic milestone for the company’s vision of becoming a leading North American supplier of lithium iron phosphate cathode active materials. The company’s recent white paper submission to the United States Department of Defense’s Defense Industrial Base Consortium has received a "Met" rating—a significant development that affirms both the technical and economic feasibility of the proposal. While a "Met"

en

00:06:04

Quadrise Chairman provides update, confirms progress...

Proactive - Interviews for investors ·

2025/06/10

Quadrise Chairman Andy Morrison joined Steve Darling from Proactive to deliver a business update highlighting continued momentum across the company’s core initiatives, despite minor delays. Morrison reported that all commitments made during the January funding round remain on track, including the near-finalisation of a key agreement with major shipping customer MSC. He acknowledged that regulatory hurdles and shipping route adjustments had extended legal timelines but stressed the deal is “very,

en

00:04:00

U.S. Global Investors CEO Frank Holmes discusses...

Proactive - Interviews for investors ·

2025/06/10

U.S. Global Investors CEO Frank Holmes joined Steve Darling from Proactive to discuss the ongoing momentum in the global travel sector and its impact on two of the firm's flagship exchange-traded funds: JETS, listed on the New York Stock Exchange, and TRIP, listed on the London Stock Exchange. Holmes highlighted that both ETFs are powered by smart beta strategies, targeting companies with strong revenue momentum despite what he described as a “negative narrative” surrounding the travel and airline

en

00:04:27

Tonix Pharmaceuticals doses first patient in Phase 2...

Proactive - Interviews for investors ·

2025/06/09

Tonix Pharmaceuticals Holdings CEO Dr Seth Lederman joined Steve Darling from Proactive to announced that the first patient has been dosed in the Phase 2 OASIS trial, a study evaluating TNX-102 SL for reducing the severity of acute stress reaction (ASR) and preventing the onset of acute stress disorder (ASD). The investigator-initiated trial is sponsored by the University of North Carolina Institute for Trauma Recovery and supported by a $3 million grant from the U.S. Department of Defense. The

en

00:03:57

Rome Resources uncovers new tin zone at Bisie North...

Proactive - Interviews for investors ·

2025/06/09

Rome Resources CEO Paul Barrett joined Steve Darling from Proactive to announce a significant new tin discovery on the eastern flank of the Mont Agoma prospect at the company’s flagship Bisie North project in eastern Democratic Republic of Congo. Drill hole MADD030, positioned northeast of known mineralization, intersected a 40-metre-wide tin-bearing zone at a shallow depth. While visual confirmation of cassiterite is limited in the weathered material, on-site Niton XRF readings indicate elevated

en

00:04:26

LinQ Minerals launches IPO to fund drilling at...

Proactive - Interviews for investors ·

2025/06/09

LinQ Minerals Executive Chair Clive Donner joined Steve Darling from Proactive to announce the company’s initial public offering (IPO) as it prepares to list on the Australian Securities Exchange (ASX). The IPO aims to raise between A$7.5 million and A$10 million, offering investors exposure to one of Australia’s most prospective gold-copper regions. Under the IPO, LinQ is issuing 37.5 million to 50 million shares at A$0.20 per share, with the offer now officially open to investors. Donner

en

00:09:18

Immunic Therapeutics reaches major milestone with...

Proactive - Interviews for investors ·

2025/06/09

Immunic Therapeutics Chief Medical Officer Dr Andreas Muehler joined Steve Darling from Proactive to announce two major developments for the company’s lead drug candidate, vidofludimus calcium (IMU-838)—a nuclear receptor-related 1 (Nurr1) activator currently being investigated for the treatment of multiple sclerosis. The company has successfully completed enrollment for both Phase 3 ENSURE trials (ENSURE-1 and ENSURE-2), each designed to assess efficacy, safety, and tolerability of vidofludimus

en

00:02:59

First Phosphate welcomes Belgian ambassador to...

Proactive - Interviews for investors ·

2025/06/09

First Phosphate Corp. CEO John Passalacqua joined Steve Darling from Proactive to highlight two major developments as the company advances its Quebec-based Bégin-Lamarche Project. Belgian Ambassador to Canada, Patrick Van Gheel, recently visited the company’s prospecting sites, describing the Bégin-Lamarche Project as well-developed and a potential model for cooperation between the European Union and Canada—particularly between Belgium and Canada. Belgium has expressed interest in seeing the project

en

00:04:31

Arrow Exploration reports strong Q1 results with 36%...

Proactive - Interviews for investors ·

2025/06/05

Arrow Exploration CEO Marshall Abbott joined Steve Darling from Proactive to share the company’s robust first-quarter performance, marked by a 36% year-over-year increase in total oil and gas revenue, reaching US$19.51 million.First-quarter earnings rose 15% to US$11.53 million, with net income of US$2.66 million, reflecting the company’s continued success in expanding production and operational efficiencies at its Colombian assets. Abbott noted that operating cash flow totaled US$14.43 million,

en

00:04:42

Cybin secures U.S. patent for program targeting...

Proactive - Interviews for investors ·

2025/06/05

Cybin Inc. CEO Doug Drysdale joined Steve Daring from Proactive to announce that the United States Patent and Trademark Office has granted U.S. patent 12,318,477, bolstering the company’s intellectual property portfolio around its CYB004 program. CYB004 is a deuterated DMT compound being developed for the treatment of generalized anxiety disorder. The patent, which offers protection until 2040, includes claims covering novel formulations of DMT and deuterated isotopologues for intramuscular (IM)

en

00:04:20

GoviEx appoints veteran metallurgist to advance...

Proactive - Interviews for investors ·

2025/06/05

Goviex Uranium Head of Investor Relations Isabel Vilela joined Steve Darling from Proactive to announce the strategic appointment of Mr. Deogratias Bukunkwe as Project / Commissioning Metallurgist for the company’s flagship Muntanga Uranium Project in Zambia. A Zambian national, Mr. Bukunkwe brings over 25 years of experience in process start-up and plant operations, particularly in the uranium and base metals sectors. His distinguished career includes senior roles at leading uranium mines such as

en

00:04:20

Faron Pharmaceuticals presents promising data at ASCO...

Proactive - Interviews for investors ·

2025/06/05

Faron Pharmaceuticals CEO Dr. Juho Jalkanen joined Steve Darling from Proactive to discuss the company’s presentation of Phase II data from its BEXMAB study during a Rapid Oral Abstract Session at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, which has recently concluded. The BEXMAB study is evaluating bexmarilimab, Faron’s novel humanized anti-Clever-1 antibody, in combination with azacitidine, the current standard-of-care, in patients with high-risk myelodysplastic

en

4,685 results

Similar Podcasts

Bloomberg Talks

Bloomberg

Minute Briefing

The Wall Street Journal

Fintech Insider Podcast by 11:FS

11:FS

Midday News

Multimedia Ghana

Best of Business

Newstalk ZB